Article Image

IPFS News Link • Food And Drug Administration / F.D.A

FDA Limits J&J's COVID-19 Vaccine Over Blood Clot Risk

• Zero Hedge

The Food and Drug Administration (FDA) on Thursday strictly limited who can receive Johnson & Johnson's Covid-19 vaccine due to a rare but serious risk of blood clots.

After 'taking another look at the data' on the risks of life-threatening blood clots, the FDA's head of vaccines, Dr. Peter Marks, said that only adults who cannot receive a different vaccine, or specifically request J&J's shot can get one, according to the Associated Press.

"If there's an alternative that appears to be equally effective in preventing severe outcomes from COVID-19, we'd rather see people opting for that," said Marks. "But we've been careful to say that-- compared to no vaccine-- this is still a better option."


midfest.info